ABSTRACT
Peripheral arterial disease of the lower extremities affects approximately 8 million people in the United States, causing significant morbidity, such as claudication and pain during ambulation and, ultimately, insufficient perfusion of the distal extremities that may yield ischemic ulceration and gangrene. It is a marker for systemic arteriosclerosis, and mortality in patients with claudication is significantly higher than in controls.1
